{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:47:02Z","timestamp":1789447622113,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1022-2","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:40:59Z","timestamp":1536050459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4682-2777","authenticated-orcid":false,"given":"Mostafa","family":"Abdelsalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abdelwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Algohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Abd","family":"El Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Eldeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Eltoraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Anber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa","family":"El Sayed Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"6","key":"1022_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/01.ccx.0000184300.68383.95","volume":"11","author":"M Schetz","year":"2005","unstructured":"Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care. 2005;11(6):555\u201365.","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"1022_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2010111124","volume":"23","author":"SS Waikar","year":"2012","unstructured":"Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012;23(1):13\u201321.","journal-title":"J Am Soc Nephrol"},{"key":"1022_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2215\/CJN.05571008","volume":"4","author":"CY Hsu","year":"2009","unstructured":"Hsu CY, et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol. 2009;4:891\u20138. PubMed: 19406959","journal-title":"Clin J Am Soc Nephrol"},{"key":"1022_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1681\/ASN.2005060668","volume":"17","author":"JL Xue","year":"2006","unstructured":"Xue JL, et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol. 2006;17:1135\u201342. PubMed: 16495381","journal-title":"J Am Soc Nephrol"},{"key":"1022_CR5","unstructured":"Berl T. American Society of Nephrology renal research report. J Am Soc Nephrol. 2005;"},{"issue":"6","key":"1022_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2215\/CJN.02070606","volume":"1","author":"W Van Biesen","year":"2006","unstructured":"Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 2006;1(6):1314\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1022_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1752-8062.2008.00053.x","volume":"1","author":"VS Vaidya","year":"2008","unstructured":"Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1(3):200\u20138.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1022_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237\u201344.","journal-title":"Kidney Int"},{"issue":"4","key":"1022_CR9","doi-asserted-by":"publisher","first-page":"e0175890","DOI":"10.1371\/journal.pone.0175890","volume":"12","author":"IO Sun","year":"2017","unstructured":"Sun IO, Shin SH, Cho AY, Yoon HJ, Chang MY, Lee KY. Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus. PLoS One. 2017;12(4):e0175890.","journal-title":"PLoS One"},{"issue":"5","key":"1022_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/sj.ki.5002697","volume":"73","author":"PL Zhang","year":"2008","unstructured":"Zhang PL, Rothblum LI, Han WK, Blasick TM, Potdar S, Bonventre JV. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int. 2008 Mar 1;73(5):608\u201314.","journal-title":"Kidney Int"},{"issue":"1","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"e84131","DOI":"10.1371\/journal.pone.0084131","volume":"9","author":"X Shao","year":"2014","unstructured":"Shao X, Tian L, Xu W, Zhang Z, Wang C, Qi C, et al. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS One. 2014;9(1):e84131. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0084131\n                    \n                  .","journal-title":"PLoS One"},{"issue":"1","key":"1022_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0009-8981(02)00177-8","volume":"323","author":"K Uchida","year":"2002","unstructured":"Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta. 2002;323(1):121\u20138.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"1022_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5414\/CNP64041","volume":"64","author":"S Herget-Rosenthal","year":"2005","unstructured":"Herget-Rosenthal S, Pietruck F, Volbracht L, Philipp T, Kribben A. Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol. 2005;64(1):41\u20136.","journal-title":"Clin Nephrol"},{"issue":"3","key":"1022_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1152\/physiolgenomics.00223.2005","volume":"25","author":"PS Yuen","year":"2006","unstructured":"Yuen PS, Jo SK, Holly MK, Hu X, Star RA. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics. 2006;25(3):375\u201386.","journal-title":"Physiol Genomics"},{"issue":"7","key":"1022_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1600-6143.2006.01352.x","volume":"6","author":"CR Parikh","year":"2006","unstructured":"Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6(7):1639\u201345.","journal-title":"Am J Transplant"},{"issue":"1","key":"1022_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2009030264","volume":"21","author":"IE Hall","year":"2010","unstructured":"Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010;21(1):189\u201397.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1022_CR17","first-page":"296","volume":"13","author":"I Ali","year":"2013","unstructured":"Ali I, A Wani W, Saleem K, Haque A. Platinum compounds: a hope for future cancer chemotherapy. Antibiotiki (Mosc). 2013;13(2):296\u2013306.","journal-title":"Antibiotiki (Mosc)"},{"issue":"7","key":"1022_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/08860220802134730","volume":"30","author":"GC Kuriakose","year":"2008","unstructured":"Kuriakose GC, Kurup MG. Evaluation of renoprotective effect of Aphanizomenon flos-aquae on cisplatin-induced renal dysfunction in rats. Ren Fail. 2008;30(7):717\u201325.","journal-title":"Ren Fail"},{"issue":"3","key":"1022_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1248\/bpb.27.366","volume":"27","author":"DG Kang","year":"2004","unstructured":"Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC, Sohn EJ, Moon MK, Lee HS. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull. 2004;27(3):366\u201370.","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"1022_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1254\/jphs.09185FP","volume":"111","author":"Y Kawai","year":"2009","unstructured":"Kawai Y, Satoh T, Hibi D, Ohno Y, Kohda Y, Miura K, Gemba M. The effect of antioxidant on development of fibrosis by cisplatin in rats. J Pharmacol Sci. 2009;111(4):433\u20139.","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"1022_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5829.2007.00142.x","volume":"6","author":"K Barabas","year":"2008","unstructured":"Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol. 2008;6(1):1\u20138.","journal-title":"Vet Comp Oncol"},{"issue":"6","key":"1022_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ndt\/gfh826","volume":"20","author":"J Labaye","year":"2005","unstructured":"Labaye J, Sarret D, Duvic C, H\u00e9rody M, Didelot F, N\u00e9d\u00e9lec G, No\u00ebl LH. Renal toxicity of oxaliplatin. Nephro Dial Transplant. 2005;20(6):1275\u20136.","journal-title":"Nephro Dial Transplant"},{"issue":"4","key":"1022_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s12032-009-9263-3","volume":"27","author":"A Ulusakarya","year":"2010","unstructured":"Ulusakarya A, Misra S, Haydar M, Habert H, Castagne V, Gumus Y, Delmas-Marsalet B, Machover D. Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Med Oncol. 2010;27(4):1425\u20136.","journal-title":"Med Oncol"},{"issue":"6","key":"1022_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/1060028014526160","volume":"48","author":"A Yaghobi Joybari","year":"2014","unstructured":"Yaghobi Joybari A, Sarbaz S, Azadeh P, Mirafsharieh SA, Rahbari A, Farasatinasab M, Mokhtari M. Oxaliplatin-induced renal tubular vacuolization. Ann Pharmacother. 2014;48(6):796\u2013800.","journal-title":"Ann Pharmacother"},{"key":"1022_CR25","doi-asserted-by":"crossref","unstructured":"Isnard-Bagnis C, Launay-Vacher V, Karie S, Deray G. Anticancer drugs. In: Clinical Nephrotoxins Renal Injury from Drug and Chemicals, edited by De Broe M, Porter G, Bennett W, Deray G, 3rd Ed., New York, Springer Scientific, 511\u2013535 2008.","DOI":"10.1007\/978-0-387-84843-3_22"},{"issue":"1","key":"1022_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0002-9343(91)90582-I","volume":"90","author":"BR McDonald","year":"1991","unstructured":"McDonald BR, Kirmani S, Vasquez M, Mehta RL. Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature. Am J Med. 1991;90(1):386\u201391.","journal-title":"Am J Med"},{"issue":"5","key":"1022_CR27","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/S0272-6386(98)70152-0","volume":"32","author":"M Agraharkar","year":"1998","unstructured":"Agraharkar M, Nerenstone S, Palmisano J, Kaplan AA. Carboplatin-related hematuria and acute renal failure. Am J Kidney Dis. 1998;32(5):e5\u20131.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1022_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1200\/JCO.2000.18.1.106","volume":"18","author":"FM Muggia","year":"2000","unstructured":"Muggia FM, Braly PS, Brady MF, Sutton G, Niemann TH, Lentz SL, Alvarez RD, Kucera PR, Small JM. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 2000;18(1):106.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1022_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0009-8981(73)90466-X","volume":"43","author":"D Heineg\u00e5rd","year":"1973","unstructured":"Heineg\u00e5rd D, Tiderstr\u00f6m G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43(3):305\u201310.","journal-title":"Clin Chim Acta"},{"key":"1022_CR30","doi-asserted-by":"crossref","unstructured":"Chaturvedi, Shalini, Takeisha Farmer, and Gordon F. Kapke. \u201cAssay validation for KIM-1: human urinary renal dysfunction biomarker.\u201d Int J Biol Sci 5.2 (2009): 128\u2013134. Print.","DOI":"10.7150\/ijbs.5.128"},{"key":"1022_CR31","doi-asserted-by":"publisher","unstructured":"KDIGO Clinical Practice Guideline for Acute Kidney Injury Kidney International Supplements (2012) 2;1 \n                    https:\/\/doi.org\/10.1038\/kisup.2012.1","DOI":"10.1038\/kisup.2012.1"},{"key":"1022_CR32","doi-asserted-by":"crossref","unstructured":"Faig J, Haughton M, Taylor RC, D\u2019Agostino RB Jr, Whelen MJ, Rodriguez KA, Bonomi M, Murea M, Porosnicu M. Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck Cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy. Am J Clin Oncol. 2017.","DOI":"10.1097\/COC.0000000000000301"},{"issue":"3","key":"1022_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.7314\/APJCP.2015.16.3.1117","volume":"16","author":"Y Prasaja","year":"2015","unstructured":"Prasaja Y, Sutandyo N, Andrajati R. Incidence of cisplatin-induced nephrotoxicity and associated factors among cancer patients in Indonesia. Asian Pac J Cancer Prev. 2015;16(3):1117\u201322.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"1022_CR34","doi-asserted-by":"publisher","first-page":"c154","DOI":"10.1159\/000312879","volume":"115","author":"F Gaspari","year":"2010","unstructured":"Gaspari F, Cravedi P, Mandal\u00e0 M, Perico N, De Leon FR, Stucchi N, Ferrari S, Labianca R, Remuzzi G, Ruggenenti P. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract. 2010;115(2):c154\u201360.","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"1022_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.kjms.2012.10.004","volume":"29","author":"HY Lin","year":"2013","unstructured":"Lin HY, Lee SC, Lin SF, Hsiao HH, Liu YC, Yang WC, Hwang DY, Hung CC, Chen HC, Guh JY. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J Med Sci. 2013;29(6):304\u201311.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"1022_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/0004563214528312","volume":"52","author":"BK Tekce","year":"2015","unstructured":"Tekce BK, Uyeturk U, Tekce H, Uyeturk U, Aktas G, Akkaya A. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage? Ann Clin Biochem. 2015;52(1):88\u201394.","journal-title":"Ann Clin Biochem"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:08:07Z","timestamp":1567537687000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1022-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved by Mansoura faculty of Medicine ethical committee. A written free informed consent was taken from all participants. Confidentiality and privacy were considered regarding participants\u2019 personal, clinical and laboratory data. All the research data are available.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"219"}}